There are 383 resources available
Discussion
Session: Personalised treatment of lung cancer brain metastases
Resources:
Webcast
Biological hallmarks of ageing: Potential therapeutic targets?
Presenter: Roberto Ferrara
Session: New insights in the treatment of geriatric patients
Resources:
Slides
Webcast
Geriatric assessment in the chest MDT
Presenter: Lore Decoster
Session: New insights in the treatment of geriatric patients
Resources:
Slides
Webcast
Can AI help guide diagnosis and treatment of special cancer populations such as the elderly?
Presenter: Andre Dekker
Session: New insights in the treatment of geriatric patients
Resources:
Slides
Webcast
What past and future trials tell us
Presenter: Romain Corre
Session: New insights in the treatment of geriatric patients
Resources:
Slides
Webcast
3MO - First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small-cell lung cancer: Updated overall survival results from the phase 3 CameL-sq trial
Presenter: Caicun Zhou
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
4MO - Final Overall Survival (OS) Data of Sintilimab Plus Pemetrexed (SPP) and Platinum as First-Line (1L) Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (AMnsqNSCLC) in the Phase 3 ORIENT -11 Study
Presenter: Yunpeng Yang
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
5MO - Patient-reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDON
Presenter: Edward Garon
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
6MO - Pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC With PD-L1 tumor proportion score <b>≥</b>50%: KEYNOTE-598 3-year follow-up
Presenter: Delvys Rodriguez Abreu
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
2MO - Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC
Presenter: Shun Lu
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast